Clincosm LogoSign in Get a demo

pancreatic ductal adenocarcinoma (pdac)

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microbiota and Metabolites Alterations in Pancreatic Head and

Completed
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • 16S rRNA amplicon sequencing and untargeted metabolomics
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Nov 27, 2023

"Effect of Screening Using Imaging on Early Detection of PDAC in

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • A blood sample for CA 19-9 (cancer detection test)
  • (no location specified)
Sep 13, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Sep 8, 2023

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Clear Cell Renal Cell Cancer (ccRCC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC) Trial ([68Ga]Ga-DPI-4452,

Not yet recruiting
  • Clear Cell Renal Cell Cancer (ccRCC)
  • +2 more
  • (no location specified)
Jan 20, 2023

Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

Recruiting
  • Malignant Solid Tumor
  • +5 more
  • GEN1042
  • +8 more
  • San Diego, California
  • +27 more
Dec 24, 2022

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Advanced Therapies for Liver Metastases

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +2 more
    • Milan, Italy
      IRCCS San Raffaele
    Aug 8, 2022

    Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Houston (Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA),

    Recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)
    • Neoadjuvant chemotherapy (NAC)
    • Houston, Texas
      Memorial Hermann Hospital
    Sep 20, 2021

    Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Reims (Blood sample)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • Blood sample
    • Reims, France
      Damien JOLLY
    Sep 29, 2020

    Non Small Cell Lung Cancer Squamous (NSCLC-Sq), Head and Neck Squamous Cell Carcinoma (HNSCC), Small Cell Lung Cancer (SCLC)

    Completed
    • Non Small Cell Lung Cancer Squamous (NSCLC-Sq)
    • +5 more
    • Huntersville, North Carolina
    • +2 more
    Dec 27, 2019

    Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Chicago (FOLFIRINOX (oxaliplatin, leucovorin, irinotecan))

    Terminated
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • FOLFIRINOX (oxaliplatin, leucovorin, irinotecan)
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Mar 15, 2019

    Circulating Tumor Cells and Onco-exosome Quantification in

    Completed
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • Blood samples
    • Portal vein blood sample
    • Bordeaux, France
      Chu de Bordeaux
    Apr 9, 2018